Clinical Heterogeneity and Different Phenotypes in Patients with

LLS Luscan–Lumish syndrome MRD70 RAPAS Rabin–Pappas syndrome SETD2 autism spectrum disorder autosomal dominant 70 intellectual developmental disorder intellectual disability overgrowth

Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
29 05 2023
Historique:
received: 11 05 2023
revised: 25 05 2023
accepted: 26 05 2023
medline: 29 6 2023
pubmed: 28 6 2023
entrez: 28 6 2023
Statut: epublish

Résumé

SETD2 belongs to the family of histone methyltransferase proteins and has been associated with three nosologically distinct entities with different clinical and molecular features: Luscan-Lumish syndrome (LLS), intellectual developmental disorder, autosomal dominant 70 (MRD70), and Rabin-Pappas syndrome (RAPAS). LLS [MIM #616831] is an overgrowth disorder with multisystem involvement including intellectual disability, speech delay, autism spectrum disorder (ASD), macrocephaly, tall stature, and motor delay. RAPAS [MIM #6201551] is a recently reported multisystemic disorder characterized by severely impaired global and intellectual development, hypotonia, feeding difficulties with failure to thrive, microcephaly, and dysmorphic facial features. Other neurologic findings may include seizures, hearing loss, ophthalmologic defects, and brain imaging abnormalities. There is variable involvement of other organ systems, including skeletal, genitourinary, cardiac, and potentially endocrine. Three patients who carried the missense variant p.Arg1740Gln in

Identifiants

pubmed: 37372360
pii: genes14061179
doi: 10.3390/genes14061179
pmc: PMC10297832
pii:
doi:

Substances chimiques

SETD2 protein, human EC 2.1.1.43

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

Nature. 2012 Apr 04;485(7397):246-50
pubmed: 22495309
Clin Genet. 2019 Jun;95(6):726-731
pubmed: 30628072
Cell. 2016 Aug 11;166(4):950-962
pubmed: 27518565
J Biol Chem. 2005 Oct 21;280(42):35261-71
pubmed: 16118227
Anticancer Res. 2010 Sep;30(9):3309-11
pubmed: 20944102
Am J Med Genet A. 2018 May;176(5):1212-1215
pubmed: 29681085
Eur J Hum Genet. 2020 Apr;28(4):469-479
pubmed: 31685998
J Autism Dev Disord. 2015 Nov;45(11):3764-70
pubmed: 26084711
Protein Sci. 2021 Jan;30(1):70-82
pubmed: 32881101
Am J Med Genet A. 2020 Sep;182(9):2037-2048
pubmed: 32710489
J Clin Endocrinol Metab. 2021 Mar 8;106(3):718-723
pubmed: 33248444
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Science. 2012 Dec 21;338(6114):1619-22
pubmed: 23160955
Gene Ther. 2018 Sep;25(6):439-449
pubmed: 29941984
Nat Commun. 2021 Jul 5;12(1):4113
pubmed: 34226540
Int J Mol Sci. 2019 Feb 27;20(5):
pubmed: 30818762
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Front Genet. 2023 Mar 21;14:1153284
pubmed: 37025455
Nucleic Acids Res. 2022 Jan 7;50(D1):D439-D444
pubmed: 34791371
J Med Genet. 2016 Nov;53(11):743-751
pubmed: 27317772
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Elife. 2014 May 06;3:e02482
pubmed: 24843002
Eur J Med Genet. 2021 May;64(5):104200
pubmed: 33766796
Am J Med Genet C Semin Med Genet. 2005 Aug 15;137C(1):53-71
pubmed: 16010678
Am J Med Genet C Semin Med Genet. 2019 Dec;181(4):509-518
pubmed: 31643139
J Med Genet. 2014 Aug;51(8):512-7
pubmed: 24852293
Oncogene. 2015 Nov 12;34(46):5699-708
pubmed: 25728682
Protein Sci. 2018 Jan;27(1):14-25
pubmed: 28710774
Sci Adv. 2021 Jan 1;7(1):
pubmed: 33523829

Auteurs

Alejandro Parra (A)

CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, 28046 Madrid, Spain.
INGEMM-Idipaz, Institute of Medical and Molecular Genetics, 28046 Madrid, Spain.
ITHACA, European Reference Network, Hospital Universitario La Paz, 28046 Madrid, Spain.

Rachel Rabin (R)

Clinical Genetic Services, Department of Pediatrics, NYU School of Medicine, New York, NY 10016, USA.

John Pappas (J)

Clinical Genetic Services, Department of Pediatrics, NYU School of Medicine, New York, NY 10016, USA.
Clinical Genetics, NYU Orthopedic Hospital, New York, NY 10010, USA.

Patricia Pascual (P)

CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, 28046 Madrid, Spain.
INGEMM-Idipaz, Institute of Medical and Molecular Genetics, 28046 Madrid, Spain.
ITHACA, European Reference Network, Hospital Universitario La Paz, 28046 Madrid, Spain.

Mario Cazalla (M)

INGEMM-Idipaz, Institute of Medical and Molecular Genetics, 28046 Madrid, Spain.

Pedro Arias (P)

CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, 28046 Madrid, Spain.
INGEMM-Idipaz, Institute of Medical and Molecular Genetics, 28046 Madrid, Spain.
ITHACA, European Reference Network, Hospital Universitario La Paz, 28046 Madrid, Spain.

Natalia Gallego-Zazo (N)

CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, 28046 Madrid, Spain.
INGEMM-Idipaz, Institute of Medical and Molecular Genetics, 28046 Madrid, Spain.
ITHACA, European Reference Network, Hospital Universitario La Paz, 28046 Madrid, Spain.

Alfredo Santana (A)

Clinical Genetics Unit, Complejo Hospitalario Universitario Insular-Materno Infantil de Las Palmas de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain.

Ignacio Arroyo (I)

Pediatrics Department, San Pedro de Alcántara Hospital, 10003 Cáceres, Spain.

Mercè Artigas (M)

Genetics Unit, Hospital de Navarra, 31008 Pamplona, Spain.

Harry Pachajoa (H)

Fundación Valle del Lili, Universidad Icesi, 760032 Cali, Colombia.

Yasemin Alanay (Y)

Division of Pediatric Genetics, Department of Pediatrics, Faculty of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul 34752, Turkey.
Rare Diseases and Orphan Drugs Application and Research Center (ACURARE), Acibadem Mehmet Ali Aydinlar University, Istanbul 34752, Turkey.

Ozlem Akgun-Dogan (O)

Division of Pediatric Genetics, Department of Pediatrics, Faculty of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul 34752, Turkey.
Rare Diseases and Orphan Drugs Application and Research Center (ACURARE), Acibadem Mehmet Ali Aydinlar University, Istanbul 34752, Turkey.

Lyse Ruaud (L)

Department of Genetics, APHP-Robert Debré University Hospital, 75019 Paris, France.
INSERM UMR1141, Neurodiderot, University of Paris Cité, 75019 Paris, France.

Nathalie Couque (N)

Department of Genetics, APHP-Robert Debré University Hospital, 75019 Paris, France.
Laboratoire de Biologie Médicale Multisites Seqoia-FMG2025, 75014 Paris, France.

Jonathan Levy (J)

Department of Genetics, APHP-Robert Debré University Hospital, 75019 Paris, France.
Laboratoire de Biologie Médicale Multisites Seqoia-FMG2025, 75014 Paris, France.

Gloria Liliana Porras-Hurtado (GL)

Línea de Investigación de Anomalías Congénitas y Enfermedades Huérfanas-Comfamiliar, Risaralda, Colombia.

Fernando Santos-Simarro (F)

Unidad de Diagnóstico Molecular y Genética Clínica, Hospital Universitario Son Espases, Idisba, 07120 Palma de Mallorca, Spain.

Maria Juliana Ballesta-Martinez (MJ)

Sección de Genética Médica, Hospital Clínico Universitario Virgen de la Arrixaca, 30120 Murcia, Spain.
Instituto Murciano de Investigación Biosanitaria (IMIB), 30120 Murcia, Spain.

Encarna Guillén-Navarro (E)

CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, 28046 Madrid, Spain.
Instituto Murciano de Investigación Biosanitaria (IMIB), 30120 Murcia, Spain.

Hugo Muñoz-Hernández (H)

Department of Biology, Institute of Molecular Biology and Biophysics, ETH Zurich, 8092 Zurich, Switzerland.

Julián Nevado (J)

CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, 28046 Madrid, Spain.
INGEMM-Idipaz, Institute of Medical and Molecular Genetics, 28046 Madrid, Spain.
ITHACA, European Reference Network, Hospital Universitario La Paz, 28046 Madrid, Spain.
Spanish OverGrowth Registry Initiative, La Paz University Hospital, 28046 Madrid, Spain.

Jair Tenorio-Castano (J)

CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, 28046 Madrid, Spain.
INGEMM-Idipaz, Institute of Medical and Molecular Genetics, 28046 Madrid, Spain.
ITHACA, European Reference Network, Hospital Universitario La Paz, 28046 Madrid, Spain.

Pablo Lapunzina (P)

CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, 28046 Madrid, Spain.
INGEMM-Idipaz, Institute of Medical and Molecular Genetics, 28046 Madrid, Spain.
ITHACA, European Reference Network, Hospital Universitario La Paz, 28046 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH